ESLOY — EssilorLuxottica
Price when we picked it (Apr 15, 2026)
$122.75
Target: $165.00 (+34.4%)
P/E Ratio
41.9
P/E Forward
25.6
Dividend
1.87%
Market Cap
$112.9B
EPS
$2.93
Consensus
Buy
What they do
EssilorLuxottica is the French-Italian giant that dominates the entire eyewear value chain. They make the lenses (Essilor: Varilux, Transitions, Crizal, Kodak Lens), design and produce the frames (Luxottica: Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Costa Del Mar, Alain Mikli), hold exclusive licenses for luxury brands (Prada, Chanel, Tiffany, Versace, Burberry, Dolce & Gabbana, Michael Kors, Coach, Ralph Lauren, Giorgio Armani), and own the stores where you buy them (LensCrafters, Sunglass Hut, Pearle Vision, Target Optical, Apex). They also own EyeMed, the #2 vision insurer in the US, completing the cycle: they insure you, examine you, sell you the frames, make the lenses, and deliver them to you. Total vertical integration. The big new growth driver is Ray-Ban Meta — the AI smart glasses they develop with Meta. They sold 7 million units in 2025 (compared to 2M combined in 2023+2024). In 2026, they launch Oakley and Prada versions, expanding the bet.
Why we like it
FY2025 was a record year: revenue €28.5B (+11.2% YoY, first double-digit growth in company history at constant exchange rates), Q4 accelerating to +18.4%, adjusted operating margin 16.0%, record free cash flow of €2.8B despite tariffs and currency. Ray-Ban Meta is the 'dominant driver' of wholesale growth — and the smart glasses market is projected to grow from 6M units in 2025 to 20M in 2026 (value from $1.2B to $5.6B). The stock fell from the 52-week high of $186.81 to $122.75 (-34%) due to fears of Apple competition (Apple's smart glasses won't arrive until 2027) and Trump tariffs — temporary challenges in a business with a near-structural monopoly. Wall Street analysts expect significant upside: 19-22 Buy / 1-2 Hold / 0-1 Sell. Eyewear isn't fashion — it's a recurring, non-discretionary expense: 2.5B people worldwide use corrective lenses and replace them every 2-3 years. Stable demand, strong pricing power, and now a growth boost via AI wearables.
Key Risk
Apple's competition in smart glasses (production expected December 2026, launch 2027) threatens Ray-Ban Meta's current advantage — the main trigger for the 34% drop from highs. If Apple captures market share with a 'better-made' product (according to Bloomberg leaks), EssilorLuxottica loses the premium that currently supports its best growth story. Other risks: Trump tariffs of up to 20% on European imports and 36% on Thailand hit US margins (40% of revenue); a class action was filed in February 2026 over price hikes post-tariffs; Warby Parker and direct-to-consumer models erode share in entry-level optics. The price vs. profit ratio of 41.89x leaves little room if earnings disappoint.
This is educational and informational content, not financial advice. Always consult a qualified financial advisor before making investment decisions.
Vectorial Data picked ESLOY on Apr 15, 2026 at $122.75.
Full Research
EssilorLuxottica (ESLOY) — Complete Research
Price: $122.75 | P/E: 41.89 | P/E Forward: 25.56 | Div Yield: 1.87% | Market Cap: $112.9B
Note: ESLOY is the ADR OTC. The primary stock trades on Euronext Paris as EL.PA (1 ESLOY ≈ 0.25 EL.PA).
What It Is
EssilorLuxottica is the global monopoly on eyewear — the result of the 2018 merger between Essilor (French lenses, #1 worldwide in ophthalmic lenses) and Luxottica (Italian frames, #1 worldwide in frames). The group controls ~60% of the eyewear market in the US and has a comparable global share. In corrective lenses specifically, they hold 42% of the global market share.
It's not just a lens company. It's a complete vertical ecosystem: they design, manufacture, license, distribute, retail, and insure. If you have glasses on your face, they probably came from some part of this company.
Business Model — Total Vertical Integration
Own Brands (Luxottica)
| Brand | Segment |
|---|---|
| Ray-Ban | Iconic, mass-premium, smart glasses |
| Oakley | Sports, performance, new Meta AI line |
| Persol | Premium Italian, handmade |
| Oliver Peoples | Luxury Californian |
| Vogue Eyewear | Accessible women's fashion |
| Arnette | Youthful, action sports |
| Costa Del Mar | Fishing, outdoor premium |
| Alain Mikli | Haute couture |
Luxury Licenses
Exclusive licenses with Prada, Chanel, Tiffany, Versace, Burberry, Dolce & Gabbana, Michael Kors, Coach, Ralph Lauren, Giorgio Armani, Brunello Cucinelli, Miu Miu, Tory Burch and more. The renewal with Prada in December 2025 was for 10 years.
Lenses (Essilor)
| Brand | Specialty |
|---|---|
| Varilux | #1 worldwide in progressive lenses |
| Transitions | Photochromic (adapt to sunlight) |
| Crizal | Premium anti-reflective |
| Kodak Lens | Licensed mass brand |
Own Retail
| Chain | Reach |
|---|---|
| LensCrafters | ~1,300 stores in the US |
| Sunglass Hut | ~2,700 stores globally |
| Pearle Vision | ~500 stores in the US |
| Target Optical | Within-Target |
| Apex by Sunglass Hut | Premium sunglasses |
| Ray-Ban Stores | Global flagship stores |
Insurance
EyeMed — the second-largest vision insurer in the US. Closes the loop: insures you, examines you, sells you the frames, makes the lenses, collects insurance.
The Catalyst: Ray-Ban Meta (Smart Glasses)
Partnership with Meta Platforms — renewed and expanded in 2024 for $5B and an additional 10 years.
Impressive Numbers
- 7 million units sold in 2025 (Ray-Ban Meta + Oakley Meta)
- vs 2 million combined in 2023+2024 → +250% YoY
- Described by the company as "the dominant driver" of wholesale growth
Exploding Market
- 2025: 6M units / $1.2B market
- 2026 projected: 20M units / $5.6B market
- EssilorLuxottica + Meta have the technical and distribution lead
2026 Expansion
- Oakley Meta HSTN — sports version, ~$360, weather-resistant (already launched)
- Prada Meta — first luxury fashion brand in smart glasses (leaked 2026)
- Next generations with integrated display (Bloomberg rumor 2026)
FY2025 Results — Historic Record
| Metric | Value | vs 2024 |
|---|---|---|
| Revenue | €28,491M | +11.2% (constant FX) |
| Q4 Revenue growth | +18.4% | Acceleration |
| Adj. Operating Margin | 16.0% | — |
| Adj. Operating Profit | €4.5B | Record |
| Free Cash Flow | €2.796B | Historic record |
| Net Income | ~€2.4B | — |
First year in EssilorLuxottica's history with double-digit annual growth at constant exchange rates.
Why Now
1. The Drop is a Gift
- 52w High: $186.81
- Current price: $122.75 → -34% from highs
- Reason for the drop: fear of Apple smart glasses + Trump tariffs + rotation out of European luxury
- Apple doesn't launch until 2027 — EssilorLuxottica has 18+ months of advantage
2. Real Monopoly with Pricing Power
- 60% US share, 42% global in corrective lenses
- Can pass tariffs to consumers without losing customers
- 2.5B people worldwide use glasses — non-discretionary demand
3. Ray-Ban Meta is a New Business
- High margin, triple-digit growth
- Meta pays for R&D; EssilorLuxottica provides distribution and brand
- Oakley and Prada extensions multiply the TAM in 2026
4. Solid 2026 Guidance
- Revenue: €27-28B
- Operating margin: 19-20% (improvement from 16% in 2025)
- Mid-single-digit growth confirmed despite tariffs
Financial Metrics
| Metric | Value |
|---|---|
| ADR Price (ESLOY) | $122.75 |
| Market Cap | $112.9B |
| P/E TTM | 41.89x |
| P/E Forward | 25.56x |
| EPS TTM | $2.93 |
| Dividend Yield | 1.87% |
| Dividend Rate | $2.25 |
| 52w High | $186.81 |
| 52w Low | $109.00 |
| Drawdown from high | -34% |
Analyst Consensus
| Metric | Value |
|---|---|
| Consensus | Buy |
| Analysts Buy | 19-22 |
| Analysts Hold | 1-2 |
| Analysts Sell | 0-1 |
| Average Target (EL.PA) | €318-326 |
| Estimated ADR Target | ~$165 |
| Upside ADR from $122.75 | +34.4% |
Risks
1. Apple Smart Glasses (the big bear case)
- Production Dec 2026, launch spring/summer 2027
- Rumored pricing: $499-$799 (premium vs Ray-Ban Meta)
- Bloomberg leak: "similar to Meta product but better built"
2. Trump Tariffs
- Up to 20% on European imports, 36% Thailand, 145% China
- Class action Feb 2026 over price hikes post-tariffs
- Mitigation: considering partial production move to the US
3. Warby Parker & DTC Erosion
- Warby Parker has gained share in entry-level ranges
- More threat to mass segment than premium
4. Premium Valuation
- P/E TTM 41.89x leaves little room for error
5. EUR/USD Currency
- Company reports in EUR; ADR in USD
Conclusion
ESLOY at $122.75 is an opportunity to buy the global eyewear monopoly at a 34% discount from highs, just as:
- They reported their best year in history (+11.2% revenue)
- They have the hottest new hardware category (Ray-Ban Meta, 7M units sold)
- The market punishes them for 2027 fears (Apple) — 18+ months of structural advantage
- Dividend 1.87% + pricing power to mitigate tariffs
- Analyst consensus Buy with ~34% upside to target
The boring business (corrective lenses for 2.5B people) anchors the defensive thesis. The exciting business (AI smart glasses) provides the upside.
Research date: Apr 15, 2026 | Next review: Oct 2026
This is not financial advice.
This is not financial advice. Consult a certified financial advisor.
The author may hold positions in the securities discussed.
Past performance does not guarantee future results.